Stroke Guide Retraction; A Better Risk Score; Bempedoic Acid Win

— Recent developments of interest in cardiovascular medicine

MedicalToday

The American Heart Association against strong opposition of the writing group, citing need for clarification on sections dealing with emergency medical systems, hospital stroke capabilities, telemedicine, brain imaging, and blood pressure, among others. (Cardiovascular Business) The guideline's recommendation expanding the window for endovascular thrombectomy to 24 hours remains in effect.

The American College of Cardiology/American Heart Association by about 40% in men and 60% in women in New Zealand, researchers found, whereas their newly-derived risk PREDICT score performed better. (The Lancet)

Novel oral agent by 18% at 12 weeks atop maximally-tolerated statin in the intent-to-treat heterozygous familial hypercholesterolemia population in top-line results of a pivotal phase III trial. (StreetInsider.com)

Stem cells were safe and associated with an 88.9% major amputation-free survival rate in peripheral artery disease, according to a small long-term study from China. (STEM CELLS Translational Medicine)

The FDA greenlighted use of the Minnesota Living with Heart Failure Questionnaire for proving efficacy of medical devices in regulatory submissions, the agency .

The agency also cleared the for ablation, while European regulators cleared the . (MassDevice)

In coronary heart disease without severe systolic dysfunction, accounted for more than half of cardiovascular deaths, with a cumulative incidence of 2.1%. (JAMA Cardiology)

predicted all-cause mortality, heart disease, and heart failure in a study of African Americans in JAMA Cardiology.

How does ? Pro-inflammatory cytokines and heart rate variability may play a role, researchers reported in Psychoneuroendocrinology.